Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Vice President, Business Development, Bristol-Myers Squibb Company
Graham joined Bristol Myers Squibb in 2002 and has transactional responsibility for the full array of collaborations covering research, clinical and commercial stage assets across BMS’ global pharmaceutical business. Graham is also responsible for Japan Partnering activities.
Prior to joining BMS, Graham was Senior Vice President, Corporate Development at 3-Dimensional Pharmaceuticals, a drug discovery company and before that Vice President, Worldwide Business Development at SmithKline Beecham Pharmaceuticals, where he spent 10 years.
Graham has successfully led and overseen numerous transaction teams involved in company acquisitions, co development and co promotion deals, compound in and out licensing, product disposals, research collaborations, patents licenses and other strategic transactions.
Originally from the UK, Graham has lived and worked in Holland, Belgium and the USA, where he has spent the last 20 years.
Graham is a fellow of the Chartered Association of Certified Accountants, United Kingdom